India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential ... but it became the first SGLT2 drug to be approved for CKD in diabetics last October ...

Aetna alleges generic drugmakers colluded to inflate prices of essential medications, with increases reaching as high as 2,762%. The lawsuit claims a "fair share" market allocation system and ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

Teva Pharmaceuticals TEVA markets an authorized generic of Victoza ... Price Action: NVO stock is down 0.46% at $87.25 during the premarket session at last check Monday.

Let's take a look at the NBA MVP odds at DraftKings Sportsbook as of Jan. 6. 2024-25 NBA MVP odds: Shai Gilgeous-Alexander: -145 (bet $10 to win $16.90 total) As of Jan. 6, Jokic is averaging 31.5 ...

The 2024-25 Premier League table promises to be tight from top to bottom as some almighty scraps will take place over the next nine months. [ MORE: Premier League 2024-25 schedule, how to watch live] ...

improved antibody internalization and enhanced the cytotoxicity of a HER2-targeting antibody drug conjugate.